We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Atlassian
TEAM
$22B
| $52.2M | 0.07% |
294,942
-1,004,377
| -77% | -$179M |
|
252
Avient
AVNT
$3.45B
| $51.4M | 0.07% |
1,177,515
-290,522
| -20% | -$12.7M |
|
253
McCormick & Company Non-Voting
MKC
$13.4B
| $51.3M | 0.07% |
+722,946
| New | +$52.6M |
|
254
Celldex Therapeutics
CLDX
$2.77B
| $51M | 0.07% |
1,377,868
+479,068
| +53% | +$18.1M |
|
255
State Street
STT
$50.9B
| $50.4M | 0.07% |
681,559
-207,561
| -23% | -$15.5M |
|
256
State Street Technology Select Sector SPDR ETF
XLK
$115B
| $50.3M | 0.07% |
445,010
-462,274
| -51% | -$48.7M |
|
257
Healthpeak Properties
DOC
$15.4B
| $50.3M | 0.07% |
2,567,748
+2,261,536
| +739% | +$43.2M |
|
258
Kimco Realty
KIM
$17.6B
| $50.3M | 0.07% |
2,582,430
-1,934,791
| -43% | -$36.2M |
|
259
MGM Resorts International
MGM
$11.7B
| $49.3M | 0.07% |
1,110,040
+706,159
| +175% | +$29.5M |
|
260
Match Group
MTCH
$8.84B
| $49.1M | 0.07% |
+1,614,652
| New | +$51M |
|
261
Shake Shack
SHAK
$2.3B
| $49M | 0.07% |
544,336
+273,822
| +101% | +$26.7M |
|
262
argenx
ARGX
$57.4B
| $48.9M | 0.07% |
113,772
-2,863
| -2% | -$1.1M |
|
263
PUT
McDonald's
MCD
$188B
| $48.9M | 0.07% |
+191,900
| New | +$50.9M |
|
264
Agios Pharmaceuticals
AGIO
$2.16B
| $48.9M | 0.07% |
1,133,735
+855,739
| +308% | +$30.9M |
|
265
Hormel Foods
HRL
$13.9B
| $48.9M | 0.07% |
1,602,732
+742,859
| +86% | +$25M |
|
|
DFS
266
DELISTED
Discover Financial Services
DFS
| $48.7M | 0.07% |
371,914
-100,335
| -21% | -$12.5M |
|
267
SPDR Gold Trust
GLD
$131B
| $48.4M | 0.06% |
225,155
-246,508
| -52% | -$53.3M |
|
268
Vertiv
VRT
$112B
| $48.4M | 0.06% |
559,077
-510,039
| -48% | -$46.4M |
|
269
Universal Health Services
UHS
$9.43B
| $48.3M | 0.06% |
261,221
+204,178
| +358% | +$36.1M |
|
270
MoonLake Immunotherapeutics
MLTX
$1.59B
| $48.3M | 0.06% |
1,098,630
+587,684
| +115% | +$24.9M |
|
271
Burlington
BURL
$22B
| $47.7M | 0.06% |
+198,853
| New | +$40.9M |
|
272
Fastenal
FAST
$54B
| $47.5M | 0.06% |
1,512,482
+1,475,666
| +4,008% | +$49.8M |
|
273
Check Point Software Technologies
CHKP
$13.3B
| $47.2M | 0.06% |
+286,326
| New | +$44.6M |
|
274
GoDaddy
GDDY
$12.3B
| $47M | 0.06% |
336,551
-520,250
| -61% | -$68.6M |
|
275
Dollar Tree
DLTR
$23.1B
| $46.9M | 0.06% |
439,101
+288,105
| +191% | +$34M |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.